Pure Bioscience

(OTC) PURE

Current Price$0.07

Market Cap$7.38M

Since IPO (1996)-100%

5 Year-89%

1 Year+5%

1 Month-27%

Pure Bioscience Financials at a Glance

Market Cap

$7.38M

Revenue (TTM)

$2.41M

Net Income (TTM)

$2.16M

EPS (TTM)

$-0.02

P/E Ratio

-3.42

Dividend

$0.00

Beta (Volatility)

0.24 (Low)

Dividend

$0.00

Beta (Volatility)

0.24 (Low)

Price

$0.07

Volume

4,590

Open

$0.06

Price

$0.07

Volume

4,590

Open

$0.06

Previous Close

$0.07

Daily Range

$0.06 - $0.07

52-Week Range

$0.04 - $0.21

Dividend

$0.00

Beta (Volatility)

0.24 (Low)

Price

$0.07

Volume

4,590

Open

$0.06

Previous Close

$0.07

Daily Range

$0.06 - $0.07

52-Week Range

$0.04 - $0.21

PURE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pure Bioscience

Industry

Household Products

Sector

Consumer Staples

Employees

CEO

Robert F. Bartlett

Website

www.purebio.com

Headquarters

El Cajon, CA 91730, US

PURE Financials

Key Financial Metrics (TTM)

Gross Margin

541%

Operating Margin

-82%

Net Income Margin

-90%

Return on Equity

Return on Capital

87%

Return on Assets

-3%

Earnings Yield

-29.24%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.38M

Shares Outstanding

111.89M

Volume

4.59K

Avg. Volume

37.95K

Financials (TTM)

Gross Profit

$1.30B

Operating Income

$2.27M

EBITDA

$2.10M

Operating Cash Flow

$2.02B

Capital Expenditure

$0.00

Free Cash Flow

$2.02B

Cash & ST Invst.

$334.00M

Total Debt

$5.24B

Pure Bioscience Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$444.00K

+13.6%

Gross Profit

$238.00K

+4.8%

Gross Margin

53.60%

N/A

Market Cap

$7.38M

N/A

Market Cap/Employee

$671.32K

N/A

Employees

N/A

Net Income

$785.00K

+1.6%

EBITDA

$683.00K

+6.1%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$5.95M

-57.6%

Accounts Receivable

$252.00K

+40.0%

Inventory

$244.00K

+225.3%

Long Term Debt

$4.01M

+0.8%

Short Term Debt

$2.14M

N/A

Return on Assets

-2.74%

N/A

Return on Invested Capital

87.43%

N/A

Free Cash Flow

$606.00K

-11.4%

Operating Cash Flow

$606.00K

-11.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

DQWSDSwiss, Inc.

DQWSDSwiss, Inc.$0.04+0.00%

EXDWExceed World, Inc.

EXDWExceed World, Inc.$0.29+0.00%

HERBYaSheng Group

HERBYaSheng Group$0.03-30.52%

CAWWCCA Industries, Inc.

CAWWCCA Industries, Inc.$0.50+0.00%

HIGRHi-Great Group Holding Company

HIGRHi-Great Group Holding Company$0.03+0.00%

NUVIEmo Capital Corp.

NUVIEmo Capital Corp.$0.01+0.00%

NPRFFNepra Foods Inc.

NPRFFNepra Foods Inc.$0.34+15.06%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About PURE

What is the current price of Pure Bioscience?

Pure Bioscience is trading at $0.07 per share.

What is the 52-week range for Pure Bioscience?

Over the past 52 weeks, Pure Bioscience has traded between $0.04 and $0.21.

How much debt does Pure Bioscience have?

As of the most recent reporting period, Pure Bioscience reported total debt of $6.14M.

How much cash does Pure Bioscience have on hand?

Pure Bioscience reported $273,000 in cash and cash equivalents in its most recent financial results.

What is Pure Bioscience’s dividend yield?

Pure Bioscience does not currently have a dividend yield.

Pure Bioscience

Pure Bioscience Financials at a Glance

PURE News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Pure Bioscience

PURE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Pure Bioscience Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PURE

What is the current price of Pure Bioscience?

What is the 52-week range for Pure Bioscience?

How much debt does Pure Bioscience have?

How much cash does Pure Bioscience have on hand?

What is Pure Bioscience’s dividend yield?

Premium Investing Services